Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis, which is considered as the hepatic manifestation of metabolic syndrome, has a great prevalence all over the world. New drugs are urgently needed for the treatment of NAFLD. This review will be to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiao-yan, Fan, Si-min, Shi, Guo-mei, Yao, Jia, Gao, Yang, Xia, Yu-guo, Chen, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302599/
https://www.ncbi.nlm.nih.gov/pubmed/32541499
http://dx.doi.org/10.1097/MD.0000000000020624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302599/
https://www.ncbi.nlm.nih.gov/pubmed/32541499
http://dx.doi.org/10.1097/MD.0000000000020624

Ejemplares similares